Re-thinking yellow fever vaccines: fighting old foes with new generation vaccines

Recent sylvatic yellow fever virus transmission in Brazil: the news from an old disease

(2020) Natalia Ingrid Oliveira Silva et al.   Virology Journal

COVID-19 vaccines: breaking record times to first-in-human trials

(2020) Young Chan Kim et al.   npj Vaccines

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

(2020) Pedro M Folegatti et al.   LANCET

Preparing for Pandemics: RNA Vaccines at the Forefront

(2020) Jesse H. Erasmus et al.   MOLECULAR THERAPY

Amplifying RNA Vaccine Development

(2020) Deborah H. Fuller et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

(2020) Merryn Voysey et al.   LANCET

Distinct YFV Lineages Co-circulated in the Central-Western and Southeastern Brazilian Regions From 2015 to 2018

(2019) Edson Delatorre et al.   Frontiers in Microbiology

Duration of Humoral and Cellular Immunity 8 Years After Administration of Reduced Doses of the 17DD-Yellow Fever Vaccine

(2019) Ismael Artur da Costa-Rocha et al.   Frontiers in Immunology

Estimating Past, Present, and Future Trends in the Global Distribution and Abundance of the Arbovirus Vector Aedes aegypti Under Climate Change Scenarios

(2019) Jing Liu-Helmersson et al.   Frontiers in Public Health

Current status, challenges and perspectives in the development of vaccines against yellow fever, dengue, Zika and chikungunya viruses

(2018) José V.J. Silva et al.   ACTA TROPICA

Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe

(2018) Florian Douam et al.   TRENDS IN MICROBIOLOGY

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

(2018) César López-Camacho et al.   Nature Communications

Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients

(2018) Nathalie Colin De Verdiere et al.   AIDS

Process intensification of EB66® cell cultivations leads to high-yield yellow fever and Zika virus production

(2018) Alexander Nikolay et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model

(2018) Justin G. Julander et al.   Frontiers in Immunology

Long-Term Protection After Fractional-Dose Yellow Fever Vaccination

(2018) Anna H.E. Roukens et al.   ANNALS OF INTERNAL MEDICINE

Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study

(2018) Dimitrios Gouglas et al.   Lancet Global Health

Yellow fever vaccination: estimating coverage

(2017) Annelies Wilder-Smith   LANCET INFECTIOUS DISEASES

Yellow fever live attenuated vaccine: A very successful live attenuated vaccine but still we have problems controlling the disease

(2017) Alan D.T. Barrett   VACCINE

Live Attenuated Yellow Fever 17D Vaccine: A Legacy Vaccine Still Controlling Outbreaks In Modern Day

(2017) Natalie D. Collins et al.   Current Infectious Disease Reports

Humoral cross-reactivity between Zika and dengue viruses: implications for protection and pathology

(2017) Lalita Priyamvada et al.   Emerging Microbes & Infections

Yellow fever vaccine: worthy friend or stealthy foe?

(2016) Stephen J. Seligman et al.   Expert Review of Vaccines

DNA-launched live-attenuated vaccines for biodefense applications

(2016) Peter Pushko et al.   Expert Review of Vaccines

Modelling a way out of yellow fever

(2016) Leo G Visser et al.   LANCET

Yellow fever vaccine supply: a possible solution

(2016) Thomas P Monath et al.   LANCET

Fractional dosing of yellow fever vaccine to extend supply: a modelling study

(2016) Joseph T Wu et al.   LANCET

Yellow Fever in Angola and Beyond — The Problem of Vaccine Supply and Demand

(2016) Alan D.T. Barrett   NEW ENGLAND JOURNAL OF MEDICINE

Current status and future prospects of yellow fever vaccines

(2015) Andrew S Beck et al.   Expert Review of Vaccines

Yellow fever

(2015) Thomas P. Monath et al.   JOURNAL OF CLINICAL VIROLOGY

Cracking the egg: An insight into egg hypersensitivity

(2015) Pathum Dhanapala et al.   MOLECULAR IMMUNOLOGY

An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures

(2015) Renata C. Pereira et al.   VACCINE

A DNA Vaccine against Yellow Fever Virus: Development and Evaluation

(2015) Milton Maciel et al.   PLoS Neglected Tropical Diseases

The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus

(2015) Moritz UG Kraemer et al.   eLife

Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone

(2014) X. Jiang et al.   JOURNAL OF GENERAL VIROLOGY

A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available

(2014) Tomohiro Ishikawa et al.   VACCINE

Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice

(2014) Irina Tretyakova et al.   VIROLOGY

Pre-existing immunity against Ad vectors

(2014) Hugues Fausther-Bovendo et al.   Human Vaccines & Immunotherapeutics

Efficacy and Duration of Immunity after Yellow Fever Vaccination: Systematic Review on the Need for a Booster Every 10 Years

(2013) Eduardo Gotuzzo et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

The Immunosuppressed Traveler

(2012) L.G. Visser   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One

Viral vectors as vaccine platforms: deployment in sight

(2011) Christine S Rollier et al.   CURRENT OPINION IN IMMUNOLOGY

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever

(2011) Birgit Schäfer et al.   PLoS One

Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model

(2011) Justin G. Julander et al.   VACCINE

Yellow Fever: A Reemerging Threat

(2010) Christina L. Gardner et al.   CLINICS IN LABORATORY MEDICINE

Is it time for a new yellow fever vaccine?

(2010) Edward B. Hayes   VACCINE

Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity

(2010) Thomas P. Monath et al.   VACCINE

Yellow fever vaccine—how does it work and why do rare cases of serious adverse events take place?

(2009) Alan DT Barrett et al.   CURRENT OPINION IN IMMUNOLOGY

Yellow Fever: 100 Years of Discovery

(2008) J. Erin Staples   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Adverse event reports following yellow fever vaccination

(2008) Nicole P. Lindsey et al.   VACCINE